Articles by Disease (Neuroblastoma)

A Review of Natural and Modified Betulinic, Ursolic and Echinocystic Acid Derivatives as Potential Antitumor and Anti-HIV Agents

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 3
Page: 525-539
Author(s): I. Baglin, A.- C. Mitaine-Offer, M. Nour, K. Tan, C. Cave and M.- A. Lacaille-Dubois

Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors

Journal: Current Pharmaceutical Design
Volume: 9
Page: 1607-1633
Author(s): Patricia H. Reggio

Radiation and Gene Therapy: Rays of Hope for the New Millennium?

Journal: Current Gene Therapy
Volume: 3
Page: 319-339
Author(s): M. Boyd, H. S. Spenning and R. J. Mairs

Immunophilins and Coupled Gating of Ryanodine Receptors

Journal: Current Topics in Medicinal Chemistry
Volume: 3
Page: 1383-1391
Author(s): Stephan E. Lehnart, Fannie Huang, Steven O. Marx and Andrew R. Marks

Death Receptor Signaling in Cancer Therapy

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 253-262
Author(s): Simone Fulda and Klaus-Michael Debatin

The Role of Iron Chelation in Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 10
Page: 1021-1034
Author(s): Joan L. Buss, Frank M. Torti and Suzy V. Torti

Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators

Journal: Current Medicinal Chemistry
Volume: 10
Page: 1035-1049
Author(s): D. B. Lovejoy and D. R. Richardson

The MYC Oncogene as a Cancer Drug Target

Journal: Current Cancer Drug Targets
Volume: 3
Page: 163-175
Author(s): Heiko Hermeking

Tumor Angiogenesis: A Potential Target In Cancer Control by Phytochemicals

Journal: Current Cancer Drug Targets
Volume: 3
Page: 205-217
Author(s): Rana P. Singh and Rajesh Agarwal

Erythropoietin: Cytoprotection in Vascular and Neuronal Cells

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 3
Page: 141-154
Author(s): Zhao Zhong Chong, Jing-Qiong Kang and Kenneth Maiese